NCT06792318 The Role of FAPI PET-CT in Diagnosing Endometriosis
| NCT ID | NCT06792318 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ziv Hospital |
| Condition | Endometriosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-03 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-03 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with suspected endometriosis scheduled for surgery will be identified. They will be asked to participate in a study evaluating the feasibility of FAPI PET-CT in diagnosing endometriosis. The results will be compared with surgical findings, pathology, and other imaging techniques if available (i.e., MRI, US).
Eligibility Criteria
Inclusion Criteria: * Female participants aged 18-45 years * Clinical suspicion of endometriosis based on symptoms * Scheduled for diagnostic/therapeutic laparoscopic surgery * Ability to understand and provide written informed consent * Completed and signed Radiation Exposure Documentation Form Exclusion Criteria: * Pregnant women or women who are breastfeeding * History of pelvic radiation therapy * Known active malignancy * Exposure to ionizing radiation for medical purposes within 12 months prior to enrollment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06792318 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06792318 currently recruiting?
Yes, NCT06792318 is actively recruiting participants. Contact the research team at israels@ziv.gov.il for enrollment information.
Where is the NCT06792318 trial being conducted?
This trial is being conducted at Safed, Israel.
Who is sponsoring the NCT06792318 clinical trial?
NCT06792318 is sponsored by Ziv Hospital. The trial plans to enroll 30 participants.